Main > ONCOLOGY (**) > GEJ Cancer MET or R PD-L1+ *** > Treatment > USA. M. PembrolizuMAb>>

---

USA. M. PembrolizuMAb>>'s subsections
(*) USA Approval Date: 2017. 09.22
>& If .. HER2/neu-Targeted Therapy
>2>Prior Fluoropyrimidine- & Pt-CT
Companion Diagnostics>
Company
GEJ: Gastro Esophageal Junction
TradeMark
TradeMark Web-Site

USA. M. PembrolizuMAb>>'s products
This section has no products